# Vaccine Therapy in Treating Patients With Metastatic Breast Cancer

> **NCT00071942** · PHASE1 · TERMINATED · sponsor: **National Cancer Institute (NCI)** · enrollment: 22 (estimated)

## Conditions studied

- Male Breast Cancer
- Recurrent Breast Cancer
- Stage IV Breast Cancer

## Interventions

- **BIOLOGICAL:** recombinant vaccinia-MUC1 vaccine
- **BIOLOGICAL:** recombinant vaccinia-TRICOM vaccine
- **OTHER:** laboratory biomarker analysis
- **PROCEDURE:** quality-of-life assessment

## Key facts

- **NCT ID:** NCT00071942
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-10
- **Primary completion:** 2007-11
- **Final completion:** —
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2013-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00071942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00071942, "Vaccine Therapy in Treating Patients With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00071942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*